episil® oral mucositis pain management episil® in an effective, safe and convenient new pain treatment for patients suffering from oral mucositis. The product is granted FDA 510(k) market clearance in the US and CE mark in EU. episil® is being launched globally by Camurus and its partners. Read more »
FluidCrystal® Injection depot Compatibility with prefilled syringes and autoinjectors, tuneable release profiles, and simple manufacturing, makes the FluidCrystal® injection depot stand out as a leading technology for daily, weekly, or monthly extended release products. Read more »
Meet Camurus at MASCC 2013 Camurus is attending the annual international symposium on cancer supportive care, MASCC in Berlin, June 27-29. If you plan to go, please do not miss the opportunity to meet with the Camurus team. Read more »
